{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:04:05Z","timestamp":1793325845105,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10096-020-03868-x","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T09:03:49Z","timestamp":1594199029000},"page":"1551-1558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The use of 3 selected lactobacillary strains in vaginal probiotic gel for the treatment of acute Candida vaginitis: a proof-of-concept study"],"prefix":"10.1007","volume":"39","author":[{"given":"Gilbert","family":"Donders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Bellen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"Oerlemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingmar","family":"Claes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateryna","family":"Ruban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Henkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Kiekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lebeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"3868_CR1","unstructured":"Martin Lopez JE (2015) Candidiasis (vulvovaginal). BMJ Clin Evid. 2015"},{"issue":"5","key":"3868_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/myc.12455","volume":"59","author":"SY Chew","year":"2016","unstructured":"Chew SY, Than LT (2016) Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches. Mycoses 59(5):262\u2013273","journal-title":"Mycoses"},{"issue":"2","key":"3868_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/ajo.12592","volume":"57","author":"A Matheson","year":"2017","unstructured":"Matheson A, Mazza D (2017) Recurrent vulvovaginal candidiasis: a review of guideline recommendations. Aust N Z J Obstet Gynaecol 57(2):139\u2013145","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"Suppl 1","key":"3868_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/myc.12292","volume":"58","author":"W Mendling","year":"2015","unstructured":"Mendling W et al (2015) Guideline: vulvovaginal candidosis (AWMF 015\/072), S2k (excluding chronic mucocutaneous candidosis). Mycoses 58(Suppl 1):1\u201315","journal-title":"Mycoses"},{"issue":"2","key":"3868_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ajog.2015.06.053","volume":"213","author":"R Romero","year":"2015","unstructured":"Romero R, Nygaard I (2015) CDC updates guidelines for treating sexually transmitted diseases. Am J Obstet Gynecol 213(2):117\u2013118","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"3868_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1258\/ijsa.2011.011012","volume":"22","author":"J Sherrard","year":"2011","unstructured":"Sherrard J et al (2011) European (IUSTI\/WHO) guideline on the management of vaginal discharge, 2011. Int J STD AIDS 22(8):421\u2013429","journal-title":"Int J STD AIDS"},{"issue":"3","key":"3868_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1701-2163(15)30316-9","volume":"37","author":"J van Schalkwyk","year":"2015","unstructured":"van Schalkwyk J, Yudin MH (2015) Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis. J Obstet Gynaecol Can 37(3):266\u2013274","journal-title":"J Obstet Gynaecol Can"},{"issue":"3","key":"3868_CR8","first-page":"151","volume":"29","author":"MC Diaz","year":"2016","unstructured":"Diaz MC et al (2016) Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin. Rev Esp Quimioter 29(3):151\u2013154","journal-title":"Rev Esp Quimioter"},{"issue":"9","key":"3868_CR9","doi-asserted-by":"publisher","first-page":"e21468","DOI":"10.5812\/jjm.21468","volume":"8","author":"Z Nasrollahi","year":"2015","unstructured":"Nasrollahi Z et al (2015) Fluconazole resistance Candida albicans in females with recurrent vaginitis and Pir1 overexpression. Jundishapur J Microbiol 8(9):e21468","journal-title":"Jundishapur J Microbiol"},{"issue":"7","key":"3868_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/OGX.0b013e3181e09621","volume":"65","author":"G Donders","year":"2010","unstructured":"Donders G (2010) Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: a review. Obstet Gynecol Surv 65(7):462\u2013473","journal-title":"Obstet Gynecol Surv"},{"issue":"3","key":"3868_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bpobgyn.2007.01.002","volume":"21","author":"GG Donders","year":"2007","unstructured":"Donders GG (2007) Definition and classification of abnormal vaginal flora. Best Pract Res Clin Obstet Gynaecol 21(3):355\u2013373","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"9\u201310","key":"3868_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.resmic.2017.04.004","volume":"168","author":"GGG Donders","year":"2017","unstructured":"Donders GGG et al (2017) Aerobic vaginitis: no longer a stranger. Res Microbiol 168(9\u201310):845\u2013858","journal-title":"Res Microbiol"},{"issue":"2","key":"3868_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/LGT.0000000000000060","volume":"19","author":"TA Rumyantseva","year":"2015","unstructured":"Rumyantseva TA et al (2015) Utility of microscopic techniques and quantitative real-time polymerase chain reaction for the diagnosis of vaginal microflora alterations. J Low Genit Tract Dis 19(2):124\u2013128","journal-title":"J Low Genit Tract Dis"},{"issue":"1","key":"3868_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1471-0528.2002.00432.x","volume":"109","author":"GG Donders","year":"2002","unstructured":"Donders GG et al (2002) Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 109(1):34\u201343","journal-title":"BJOG"},{"issue":"7","key":"3868_CR15","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jiac.2015.03.011","volume":"21","author":"H Mikamo","year":"2015","unstructured":"Mikamo H et al (2015) Efficacy and safety of a single oral 150 mg dose of fluconazole for the treatment of vulvovaginal candidiasis in Japan. J Infect Chemother 21(7):520\u2013526","journal-title":"J Infect Chemother"},{"issue":"10","key":"3868_CR16","first-page":"1049","volume":"62","author":"S Akhtar","year":"2012","unstructured":"Akhtar S et al (2012) Efficacy of itraconazole versus fluconazole in vaginal candidiasis. J Pak Med Assoc 62(10):1049\u20131052","journal-title":"J Pak Med Assoc"},{"issue":"2","key":"3868_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ajog.2007.10.786","volume":"198","author":"E Pitsouni","year":"2008","unstructured":"Pitsouni E, Iavazzo C, Falagas ME (2008) Itraconazole vs fluconazole for the treatment of uncomplicated acute vaginal and vulvovaginal candidiasis in nonpregnant women: a metaanalysis of randomized controlled trials. Am J Obstet Gynecol 198(2):153\u2013160","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"3868_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1439-0507.2009.01754.x","volume":"54","author":"GG Donders","year":"2011","unstructured":"Donders GG et al (2011) Self-elimination of risk factors for recurrent vaginal candidosis. Mycoses 54(1):39\u201345","journal-title":"Mycoses"},{"issue":"1","key":"3868_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3109\/13693786.2010.497972","volume":"49","author":"AB Guzel","year":"2011","unstructured":"Guzel AB et al (2011) Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species. Med Mycol 49(1):16\u201325","journal-title":"Med Mycol"},{"issue":"4","key":"3868_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ctim.2012.01.004","volume":"20","author":"CJ Watson","year":"2012","unstructured":"Watson CJ, Pirotta M, Myers SP (2012) Use of complementary and alternative medicine in recurrent vulvovaginal candidiasis--results of a practitioner survey. Complement Ther Med 20(4):218\u2013221","journal-title":"Complement Ther Med"},{"key":"3868_CR21","doi-asserted-by":"crossref","unstructured":"Grinceviciene S et al. (2018) Sexual behaviour and extra-genital colonisation in women treated for recurrent Candida vulvo-vaginitis. Mycoses","DOI":"10.1111\/myc.12825"},{"issue":"6","key":"3868_CR22","doi-asserted-by":"publisher","first-page":"613.e1","DOI":"10.1016\/j.ajog.2008.06.029","volume":"199","author":"G Donders","year":"2008","unstructured":"Donders G et al (2008) Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial). Am J Obstet Gynecol 199(6):613.e1\u2013613.e9","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"3868_CR23","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJMoa033114","volume":"351","author":"JD Sobel","year":"2004","unstructured":"Sobel JD et al (2004) Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med 351(9):876\u2013883","journal-title":"N Engl J Med"},{"issue":"10","key":"3868_CR24","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/j.1471-0528.2008.01830.x","volume":"115","author":"GG Donders","year":"2008","unstructured":"Donders GG et al (2008) Mannose-binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis. BJOG 115(10):1225\u20131231","journal-title":"BJOG"},{"issue":"4","key":"3868_CR25","doi-asserted-by":"publisher","first-page":"e12811","DOI":"10.1111\/aji.12811","volume":"79","author":"GGG Donders","year":"2018","unstructured":"Donders GGG et al (2018) Is non-response to fluconazole maintenance therapy for recurrent Candida vaginitis related to sensitization to atopic reactions? Am J Reprod Immunol 79(4):e12811","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"3868_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1080\/21505594.2016.1237332","volume":"8","author":"LL Bradford","year":"2017","unstructured":"Bradford LL, Ravel J (2017) The vaginal mycobiome: a contemporary perspective on fungi in women's health and diseases. Virulence 8(3):342\u2013351","journal-title":"Virulence"},{"issue":"3","key":"3868_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1157\/13116753","volume":"26","author":"R Martin","year":"2008","unstructured":"Martin R et al (2008) Vaginal microbiota: composition, protective role, associated pathologies, and therapeutic perspectives. Enferm Infecc Microbiol Clin 26(3):160\u2013167","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"3868_CR28","doi-asserted-by":"crossref","unstructured":"Matsuda Y et al. (2018) Culture supernatants of Lactobacillus gasseri and L. crispatus inhibit Candida albicans biofilm formation and adhesion to HeLa cells. Mycopathologia","DOI":"10.1007\/s11046-018-0259-4"},{"issue":"6","key":"3868_CR29","doi-asserted-by":"publisher","first-page":"e0131220","DOI":"10.1371\/journal.pone.0131220","volume":"10","author":"C Parolin","year":"2015","unstructured":"Parolin C et al (2015) Isolation of vaginal lactobacilli and characterization of anti-Candida activity. PLoS One 10(6):e0131220","journal-title":"PLoS One"},{"key":"3868_CR30","doi-asserted-by":"crossref","unstructured":"Donders GGG, Bellen G, Ruban KS (2018) Abnormal vaginal microbioma is associated with severity of localized provoked vulvodynia. Role of aerobic vaginitis and Candida in the pathogenesis of vulvodynia. Eur J Clin Microbiol Infect Dis","DOI":"10.1007\/s10096-018-3299-2"},{"issue":"4","key":"3868_CR31","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1067\/mob.2002.126285","volume":"187","author":"GG Donders","year":"2002","unstructured":"Donders GG et al (2002) Impaired tolerance for glucose in women with recurrent vaginal candidiasis. Am J Obstet Gynecol 187(4):989\u2013993","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"3868_CR32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/myc.12626","volume":"60","author":"S Grinceviciene","year":"2017","unstructured":"Grinceviciene S et al (2017) Non-response to fluconazole maintenance treatment (ReCiDiF regimen) for recurrent vulvovaginal candidosis is not related to impaired glucose metabolism. Mycoses 60(8):546\u2013551","journal-title":"Mycoses"},{"issue":"4","key":"3868_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1055-3290(06)60216-1","volume":"12","author":"AB Williams","year":"2001","unstructured":"Williams AB et al (2001) Evaluation of two self-care treatments for prevention of vaginal candidiasis in women with HIV. J Assoc Nurses AIDS Care 12(4):51\u201357","journal-title":"J Assoc Nurses AIDS Care"},{"issue":"5","key":"3868_CR34","doi-asserted-by":"publisher","first-page":"353","DOI":"10.7326\/0003-4819-116-5-353","volume":"116","author":"E Hilton","year":"1992","unstructured":"Hilton E et al (1992) Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med 116(5):353\u2013357","journal-title":"Ann Intern Med"},{"key":"3868_CR35","first-page":"CD010496","volume":"11","author":"HY Xie","year":"2017","unstructured":"Xie HY et al (2017) Probiotics for vulvovaginal candidiasis in non-pregnant women. Cochrane Database Syst Rev 11:CD010496","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"3868_CR36","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.contraception.2010.08.007","volume":"83","author":"GG Donders","year":"2011","unstructured":"Donders GG et al (2011) Vaginal flora changes on pap smears after insertion of levonorgestrel-releasing intrauterine device. Contraception 83(4):352\u2013356","journal-title":"Contraception"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03868-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-020-03868-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03868-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:28:27Z","timestamp":1619742507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-020-03868-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["3868"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-03868-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"assertion":[{"value":"28 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Ingmar Claes is an employee of YUN NV, and other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Central Ethical Committee of the University Hospital Antwerp and the local ethical committee (B300201628296 \u2013 16\/7\/66).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent is signed by all patients prior to inclusion.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}